From Yahoo Finance: 2025-05-21 20:31:00

On Wednesday, 10 firms, including Moderna, Inc., saw a significant decline in share prices amid government policies and poor earnings. The Dow Jones, S&P 500, and Nasdaq also fell by 1.91%, 1.61%, and 1.41% respectively. The list of underperforming companies was based on market capitalization and trading volume criteria.

Moderna, Inc. experienced a 7.82% drop in share prices, closing at $25.80 due to withdrawing its flu and COVID combination vaccine approval application. The FDA’s requirement for new clinical trials for COVID boosters added to investor concerns. Despite this, Moderna narrowed its net loss in Q1 and aims for revenues between $1.5B and $2.5B for the year.

Overall, Moderna ranks 8th on the list of firms with declining performance. While it shows investment potential, AI stocks are seen as more promising for higher returns in a shorter time frame. Consider exploring an undervalued AI stock with significant upside potential compared to popular AI stocks in the market.

Read more: Why Moderna, Inc. (MRNA) Crashed Today